Mukai Masaya, Sato Shinkichi, Komatsu Nobukazu, Nishida Tomomi, Shiba Kazuaki, Ito Isao, Nakasaki Hisao, Makuuchi Hiroyasu
Tokai University Oiso Hospital, Department of Surgery, Kanagawa 259-0198, Japan.
Oncol Rep. 2003 Sep-Oct;10(5):1165-9.
The aim of this study was to investigate whether it was possible to select patients with Dukes' C primary colorectal cancer who had a high risk of metastasis and recurrence. Among 434 patients who underwent surgical resection of primary colorectal cancer, 115 patients (26.5%) had Dukes' C cancer. Among them, 35 patients (30.45%) suffered from metastasis/recurrence postoperatively. Thirty-two patients with recurrence for whom complete follow-up was possible (recurrence group) and 32 patients who survived for at least 5 years without recurrence (non-recurrence group) were compared by immunohistochemical staining of resected lymph nodes for cytokeratin using two antibodies (AE1/AE3 and CAM 5.2). AE1/AE3 staining was positive in 93.85% of the recurrence group versus 68.85% of the non-recurrence group (p=0.0250), while CAM 5.2 staining was positive in 84.45% vs. 53.15%, respectively (p=0.0152). The occult neoplastic cell count (mean +/- SD) in the peripheral lymph node sinuses was 6.28+/-5.17 vs. 2.38+/-3.03 (p=0.0002) in the AE1/AE3-positive patients from the recurrence and non-recurrence groups, while it was 5.13+/-4.84 vs. 1.53+/-2.37 (p=0.0003) in the CAM 5.2-positive patients in each group. Accordingly, the immunohistochemical positivity rate for both AE1/AE3 and CAM 5.2, as well as the occult neoplastic cell count, were significantly higher in the recurrence group. These results suggest that patients with Dukes' C primary colorectal cancer who have a higher risk of recurrence can be selected by immunostaining of resected lymph nodes for cytokeratin.
本研究的目的是调查是否有可能筛选出具有高转移和复发风险的Dukes' C期原发性结直肠癌患者。在434例行原发性结直肠癌手术切除的患者中,115例(26.5%)患有Dukes' C期癌症。其中,35例(30.45%)术后发生转移/复发。对32例有完整随访记录的复发患者(复发组)和32例至少存活5年无复发的患者(非复发组),使用两种抗体(AE1/AE3和CAM 5.2)对切除淋巴结进行细胞角蛋白免疫组化染色并比较。复发组中AE1/AE3染色阳性率为93.85%,非复发组为68.85%(p=0.0250),而CAM 5.2染色阳性率分别为84.45%和53.15%(p=0.0152)。复发组和非复发组AE1/AE3阳性患者外周淋巴结窦中隐匿性肿瘤细胞计数(均值±标准差)分别为6.28±5.17和2.38±3.03(p=0.0002),而每组CAM 5.2阳性患者分别为5.13±4.84和1.53±2.37(p=0.0003)。因此,复发组中AE1/AE3和CAM 5.2的免疫组化阳性率以及隐匿性肿瘤细胞计数均显著更高。这些结果表明,通过对切除淋巴结进行细胞角蛋白免疫染色,可以筛选出具有较高复发风险的Dukes' C期原发性结直肠癌患者。